At least 89 per cent of Indian technology service enterprises have initiated generative AI (GenAI) proof-of-concept (POC) ...
As healthcare providers modernise their systems, GenAI is being deployed to address some of the sector’s most pressing ...
machine learning has demonstrated its impact across virtually every industry in some capacity. Yet, over two years later, many enterprises find themselves stuck in the proof-of-concept (PoC ...
GenAI could boost productivity in India’s retail industry by 35-37% in five years: EY India report
According to an EY India report, Generative AI could boost productivity in India's retail sector by 35-37% over the next five years, with 48% of businesses already testing AI solutions.
Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo g ...
Generative AI could enhance productivity in Indias retail sector by up to 37% within five years, according to EY India. The ...
Q4 2024 Earnings Call Transcript February 13, 2025 Blueprint Medicines Corporation misses on earnings expectations. Reported ...
India’s pharma and healthcare sectors eye 30-40% productivity gains with GenAI adoption: EY report
Our Bureau, Bengaluru Tuesday, February 18, 2025, 16:45 Hrs [IST] ...
The adoption of generative artificial intelligence (GenAI) is set to boost productivity in India's USD 254-billion software ...
AI adoption in risk has reached a pivotal stage. According to our new Jaywing research, 65% of UK financial institutions have ...
Tevogen Bio remains steadfast in its mission to pioneer accessible and affordable precision medicine while advocating for fair and transparent market participation.
The change was made to ensure neighborhoods would have more access to locally grown produce and fresh food options.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback